Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	69.8	57.42	68.18	93.73	22.92
Short-Term Investments	-	-	-	0.57	0.55
Cash & Short-Term Investments	69.8	57.42	68.18	94.3	23.47
Cash Growth	21.56%	-15.78%	-27.69%	301.79%	43.57%
Other Receivables	2.79	3.13	2.31	1.82	4.23
Receivables	2.79	3.13	2.31	1.82	4.23
Prepaid Expenses	0.33	0.97	3.78	2.8	1.62
Other Current Assets	1.85	2.23	0.92	0.41	0.41
Total Current Assets	74.76	63.76	75.2	99.32	29.73
Property, Plant & Equipment	0.98	1.65	2.22	2.53	1.57
Other Intangible Assets	0.64	1.09	-	24.56	31.65
Total Assets	76.39	66.5	77.41	126.42	62.95
Accounts Payable	2.68	2.35	3.49	2.29	3.17
Accrued Expenses	4.57	5.75	5.64	4.02	4.32
Current Portion of Long-Term Debt	5.54	-	13.33	-	-
Current Portion of Leases	0.71	0.65	0.56	0.62	0.64
Current Income Taxes Payable	-	-	-	1.52	-
Other Current Liabilities	0.36	0.74	1.36	4.1	0.44
Total Current Liabilities	13.85	9.49	24.38	12.54	8.57
Long-Term Debt	-	4.39	-	14.38	16.14
Long-Term Leases	0.19	0.91	1.48	1.75	1.16
Other Long-Term Liabilities	1.39	1.18	0.16	9.74	52.05
Total Liabilities	15.42	15.96	26.01	38.42	77.92
Common Stock	3.06	2.78	2.48	1.76	1.02
Additional Paid-In Capital	539.64	486.11	476.52	247.46	161.79
Retained Earnings	-462.88	-419.63	-404.58	-296.97	-309.69
Treasury Stock	-	-1.23	-1.34	-	-
Comprehensive Income & Other	-18.85	-17.49	-21.69	135.76	131.92
Shareholders' Equity	60.97	50.54	51.4	88	-14.97
Total Liabilities & Equity	76.39	66.5	77.41	126.42	62.95
Total Debt	6.43	5.95	15.37	16.76	17.94
Net Cash (Debt)	63.37	51.47	52.81	77.54	5.53
Net Cash Growth	23.13%	-2.54%	-31.89%	1301.34%	-
Net Cash Per Share	0.43	0.39	0.44	0.70	0.08
Filing Date Shares Outstanding	159	140.01	124.74	116.73	108
Total Common Shares Outstanding	155.15	140	124.74	116.73	67.54
Working Capital	60.92	54.27	50.82	86.78	21.16
Book Value Per Share	0.39	0.36	0.41	0.75	-0.22
Tangible Book Value	60.33	49.45	51.4	63.44	-46.62
Tangible Book Value Per Share	0.39	0.35	0.41	0.54	-0.69
Machinery	0.49	0.5	0.61	0.35	0.2
Leasehold Improvements	0.71	0.71	0.68	0.56	0.16

Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q